INV-101, a cannabinoid receptor-1 inverse agonist, reduces fibrosis in a bleomycin mouse model of IPF
G. Crater (Raleigh, United States), G. Gaucher (Montreal, Canada), M. Harvey (Montreal, Canada), F. Ravenelle (Montreal, Canada)
Source: International Congress 2022 – Promising new approaches in idiopathic interstitial pneumonias
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Crater (Raleigh, United States), G. Gaucher (Montreal, Canada), M. Harvey (Montreal, Canada), F. Ravenelle (Montreal, Canada). INV-101, a cannabinoid receptor-1 inverse agonist, reduces fibrosis in a bleomycin mouse model of IPF. 1943
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|